HT
AGN

HAP Trading’s Allergan plc AGN Stock Holding History

HAP Trading’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-600,859
Closed -$140M – 1350
2016
Q4 		$126M Buy
+600,859
New +$124M 6.33% 1

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

HAP Trading's AGN Position: Q1 2017 in Review

HAP Trading sold out of Allergan plc (AGN) in Q1 2017, closing a stake of 600,859 shares — an estimated $140M sold.

HAP Trading first reported a position in AGN in Q4 2016 and held it in 1 quarter. The position peaked at $126M in Q4 2016. 1,104 funds tracked by Wall St. Rank hold AGN as of Q1 2017.

  • HAP Trading reported no remaining Allergan plc position as of Q1 2017 after selling out during the quarter.
  • HAP Trading sold 600,859 Allergan plc shares in Q1 2017, an estimated $140M.
  • HAP Trading first reported a position in Allergan plc in Q4 2016 and held it in 1 quarter.
  • HAP Trading's Allergan plc position peaked at $126M in Q4 2016.
  • 1,104 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on HAP Trading's 13F filing for Q1 2017, filed 12 May 2017.